🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Unknown
Location
Hunan Center for Disease Control and Prevention
Start Date
2021-12-10
Trial ID
NCT06314685
This study was designed to evaluate the antibody response to a Menactra® bo...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00777790
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
The purpose of this study is to describe the safety and immunogenicity of M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07710872
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
The primary phase of this study is evaluating the safety of Hib-MenCY-TT va...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09
Trial ID
NCT00345579